MAPT and Alzheimer disease: Increased Tau phosphorylation was observed by the miR-124-inhibitor in SH-WT cells, but its decrease was achieved by the mimic in iNEU-PSEN cells, suggesting a potential beneficial effect in AD pathology, already proposed in a previous study [49].